{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T06:06:56Z","timestamp":1773554816387,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Breast Cancer Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12609-020-00384-x","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T14:02:30Z","timestamp":1603029750000},"page":"275-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Accelerated Partial Breast Irradiation (APBI): Where Are We Now?"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3930-9713","authenticated-orcid":false,"given":"Mira","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,18]]},"reference":[{"issue":"16","key":"384_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233\u201341. https:\/\/doi.org\/10.1056\/NEJMoa022152.","journal-title":"N Engl J Med"},{"issue":"16","key":"384_CR2","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa020989","volume":"347","author":"U Veronesi","year":"2002","unstructured":"Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227\u201332. https:\/\/doi.org\/10.1056\/NEJMoa020989.","journal-title":"N Engl J Med"},{"issue":"6","key":"384_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513\u201320. https:\/\/doi.org\/10.1056\/NEJMoa0906260.","journal-title":"N Engl J Med"},{"issue":"11","key":"384_CR4","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086\u201394. https:\/\/doi.org\/10.1016\/S1470-2045(13)70386-3.","journal-title":"Lancet Oncol"},{"issue":"7","key":"384_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1023\/A:1011136326943","volume":"12","author":"U Veronesi","year":"2001","unstructured":"Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12(7):997\u20131003.","journal-title":"Ann Oncol"},{"issue":"2","key":"384_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0360-3016(95)02001-R","volume":"33","author":"I Gage","year":"1995","unstructured":"Gage I, Recht A, Gelman R, Nixon AJ, Silver B, Bornstein BA, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33(2):245\u201351. https:\/\/doi.org\/10.1016\/0360-3016(95)02001-R.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"384_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ijrobp.2004.04.012","volume":"60","author":"FA Vicini","year":"2004","unstructured":"Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004;60(3):722\u201330. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.04.012.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"384_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-017-4121-z","volume":"162","author":"M Perez","year":"2017","unstructured":"Perez M, Schootman M, Hall LE, Jeffe DB. Accelerated partial breast irradiation compared with whole breast radiation therapy: a breast cancer cohort study measuring change in radiation side-effects severity and quality of life. Breast Cancer Res Treat. 2017;162(2):329\u201342. https:\/\/doi.org\/10.1007\/s10549-017-4121-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"10015","key":"384_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"V Strnad","year":"2016","unstructured":"Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387(10015):229\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(15)00471-7.","journal-title":"Lancet."},{"issue":"2","key":"384_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.radonc.2013.05.008","volume":"108","author":"C Polgar","year":"2013","unstructured":"Polgar C, Fodor J, Major T, Sulyok Z, Kasler M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108(2):197\u2013202. https:\/\/doi.org\/10.1016\/j.radonc.2013.05.008.","journal-title":"Radiother Oncol"},{"issue":"10","key":"384_CR11","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1245\/s10434-013-3158-4","volume":"20","author":"C Shah","year":"2013","unstructured":"Shah C, Badiyan S, Ben Wilkinson J, Vicini F, Beitsch P, Keisch M, et al. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite((R)) breast brachytherapy registry trial. Ann Surg Oncol. 2013;20(10):3279\u201385. https:\/\/doi.org\/10.1245\/s10434-013-3158-4.","journal-title":"Ann Surg Oncol"},{"issue":"9917","key":"384_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","volume":"383","author":"JS Vaidya","year":"2014","unstructured":"Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383(9917):603\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(13)61950-9.","journal-title":"Lancet."},{"issue":"13","key":"384_CR13","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","volume":"14","author":"U Veronesi","year":"2013","unstructured":"Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14(13):1269\u201377. https:\/\/doi.org\/10.1016\/S1470-2045(13)70497-2.","journal-title":"Lancet Oncol"},{"issue":"10215","key":"384_CR14","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","volume":"394","author":"TJ Whelan","year":"2019","unstructured":"\u2022\u2022 Whelan TJ, Julian JA, Berrang TS, Kim DH, Germain I, Nichol AM, et al. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet. 2019;394(10215):2165\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(19)32515-2. This randomized trial of external beam radiation therapy based accelerated partial breast irradiation (APBI) delivered as 38.5Gy\/10 fractions, twice daily, compared to whole breast irradiation demonstrated non-inferior local control after APBI but worse long term breast cosmetic outcomes.","journal-title":"Lancet"},{"issue":"10215","key":"384_CR15","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","volume":"394","author":"FA Vicini","year":"2019","unstructured":"\u2022\u2022 Vicini FA, Cecchini RS, White JR, Arthur DW, Julian TB, Rabinovitch RA, et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019;394(10215):2155\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(19)32514-0. This randomized trial of external beam (38.5Gy\/10 fractions, twice daily) or brachytherapy based APBI compared to WBI was unable to demonstrate equivalent local control at ten years between the treatment arms.","journal-title":"Lancet"},{"issue":"4","key":"384_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","volume":"51","author":"L Livi","year":"2015","unstructured":"Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51(4):451\u201363. https:\/\/doi.org\/10.1016\/j.ejca.2014.12.013.","journal-title":"Eur J Cancer"},{"issue":"5","key":"384_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ijrobp.2013.08.046","volume":"87","author":"N Rodriguez","year":"2013","unstructured":"Rodriguez N, Sanz X, Dengra J, Foro P, Membrive I, Reig A, et al. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2013;87(5):1051\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.08.046.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10099","key":"384_CR18","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","volume":"390","author":"CE Coles","year":"2017","unstructured":"\u2022\u2022 Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017;390(10099):1048\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(17)31145-5. This three-arm non-inferiority randomized trial of APBI (40Gy\/15 daily fractions), WBI (40Gy\/15 daily fractions), or reduced dose WBI (36Gy with 40Gy to the partial breast) demonstrated non-inferiority of partial breast irradiation and improved breast toxicity after 5 years of follow up.","journal-title":"Lancet"},{"issue":"32","key":"384_CR19","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1200\/JCO.2013.50.5511","volume":"31","author":"IA Olivotto","year":"2013","unstructured":"Olivotto IA, Whelan TJ, Parpia S, Kim DH, Berrang T, Truong PT, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31(32):4038\u201345. https:\/\/doi.org\/10.1200\/JCO.2013.50.5511.","journal-title":"J Clin Oncol"},{"issue":"2","key":"384_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1470-2045(17)30011-6","volume":"18","author":"C Polgar","year":"2017","unstructured":"\u2022 Polgar C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(2):259\u201368. https:\/\/doi.org\/10.1016\/S1470-2045(17)30011-6. In this randomized trial women were randomized to receive interstitial brachytherapy or whole breast irradiation. In this publication the authors demonstrate similar toxicity and breast cosmetic outcomes between the treatment arms at 5 years.","journal-title":"Lancet Oncol"},{"key":"384_CR21","doi-asserted-by":"publisher","unstructured":"\u2022 White JR, Winter K, Cecchini RS, Vicini FA, Arthur DW, Kuske RR et al. Cosmetic outcome from post lumpectomy whole breast irradiation (WBI) versus partial breast irradiation (PBI) on the NRG Oncology\/NSABP B39-RTOG 0413 Phase III clinical trial. IJROBP. 2019;105(1). https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.384. The authors of the NSABP B-39\/RTOG 0413 randomized clinical trial present breast cosmetic outcomes after APBI delivered with EBRT or brachytherapy techniques, or WBI.","DOI":"10.1016\/j.ijrobp.2019.06.384"},{"key":"384_CR22","doi-asserted-by":"crossref","unstructured":"\u2022 Meattini I, Saleva C, Lucidi S, lo Russo M, Scotti V, Desideri I et al. Accelerated partial breast or whole breast irradiation after breast conservation surgery for patients with early breast cancer: 10-year follow up results of the APBI IMRT Florence randomized phase 3 trial [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10\u201314; San Antonio, TX. Philadelphia (PA): AACR. Cancer Res. 2020;80:Abstract nr GS4\u201306.The authors of the University of Florence randomized trial of external beam based APBI (30Gy\/5 fractions delivered on non-consecutive days) compared to WBI presented 10 year outcome data. The authors report similar breast cancer outcomes between treatment arms and less adverse breast cosmesis after APBI.","DOI":"10.1158\/1538-7445.SABCS19-GS4-06"},{"issue":"2","key":"384_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","volume":"7","author":"C Correa","year":"2017","unstructured":"Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7(2):73\u20139. https:\/\/doi.org\/10.1016\/j.prro.2016.09.007.","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"384_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0936-6555(05)80900-8","volume":"5","author":"GG Ribeiro","year":"1993","unstructured":"Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol). 1993;5(5):278\u201383.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"384_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","volume":"74","author":"BD Smith","year":"2009","unstructured":"Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74(4):987\u20131001. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.02.031.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"384_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","volume":"33","author":"B McCormick","year":"2015","unstructured":"McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33(7):709\u201315. https:\/\/doi.org\/10.1200\/JCO.2014.57.9029.","journal-title":"J Clin Oncol"},{"issue":"33","key":"384_CR27","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","volume":"33","author":"LJ Solin","year":"2015","unstructured":"Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, et al. Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol. 2015;33(33):3938\u201344. https:\/\/doi.org\/10.1200\/JCO.2015.60.8588.","journal-title":"J Clin Oncol"},{"key":"384_CR28","doi-asserted-by":"publisher","unstructured":"Vicini FA, Cecchini RS, White JR, Julian TB, Arthur DW, Rabinovitch RA et al. Primary results of NSABP B-39\/RTOG 0413 (NRG Oncology): a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. AACR. 2019;79(4). https:\/\/doi.org\/10.1158\/1538-7445.SABCS18-GS4-04.","DOI":"10.1158\/1538-7445.SABCS18-GS4-04"},{"issue":"2","key":"384_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ijrobp.2004.03.012","volume":"60","author":"DW Weed","year":"2004","unstructured":"Weed DW, Yan D, Martinez AA, Vicini FA, Wilkinson TJ, Wong J. The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2004;60(2):484\u201392. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.03.012.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"384_CR30","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.ijrobp.2009.04.089","volume":"76","author":"M Dzhugashvili","year":"2010","unstructured":"Dzhugashvili M, Pichenot C, Dunant A, Balleyguier C, Delaloge S, Mathieu MC, et al. Surgical clips assist in the visualization of the lumpectomy cavity in three-dimensional conformal accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76(5):1320\u20134. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.089.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"384_CR31","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ijrobp.2009.09.025","volume":"78","author":"T Shaikh","year":"2010","unstructured":"Shaikh T, Chen T, Khan A, Yue NJ, Kearney T, Cohler A, et al. Improvement in interobserver accuracy in delineation of the lumpectomy cavity using fiducial markers. Int J Radiat Oncol Biol Phys. 2010;78(4):1127\u201334. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.025.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"384_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2011.12.021","volume":"103","author":"LJ Boersma","year":"2012","unstructured":"Boersma LJ, Janssen T, Elkhuizen PH, Poortmans P, van der Sangen M, Scholten AN, et al. Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines. Radiother Oncol. 2012;103(2):178\u201382. https:\/\/doi.org\/10.1016\/j.radonc.2011.12.021.","journal-title":"Radiother Oncol"},{"issue":"2","key":"384_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ijrobp.2008.04.041","volume":"73","author":"TS Berrang","year":"2009","unstructured":"Berrang TS, Truong PT, Popescu C, Drever L, Kader HA, Hilts ML, et al. 3D ultrasound can contribute to planning CT to define the target for partial breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73(2):375\u201383. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.04.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"384_CR34","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.ijrobp.2009.01.009","volume":"75","author":"JT Hepel","year":"2009","unstructured":"Hepel JT, Tokita M, MacAusland SG, Evans SB, Hiatt JR, Price LL, et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009;75(5):1290\u20136. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.01.009.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"384_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2009.01.041","volume":"76","author":"R Jagsi","year":"2010","unstructured":"Jagsi R, Ben-David MA, Moran JM, Marsh RB, Griffith KA, Hayman JA, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76(1):71\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.01.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"384_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ijrobp.2005.06.028","volume":"64","author":"DE Wazer","year":"2006","unstructured":"Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64(2):489\u201395. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.06.028.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"384_CR37","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ijrobp.2014.12.040","volume":"91","author":"D Peterson","year":"2015","unstructured":"Peterson D, Truong PT, Parpia S, Olivotto IA, Berrang T, Kim DH, et al. Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis. Int J Radiat Oncol Biol Phys. 2015;91(5):968\u201376. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.12.040.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR38","unstructured":"Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation. Available online: https:\/\/ClinicalTrials.gov\/show\/NCT02637024. Accessed May 18, 2020."},{"issue":"5","key":"384_CR39","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1016\/j.prro.2019.04.002","volume":"9","author":"P Grendarova","year":"2019","unstructured":"Grendarova P, Roumeliotis M, Quirk S, Lesiuk M, Craighead P, Liu HW, et al. One-year cosmesis and fibrosis from ACCEL: accelerated partial breast irradiation (APBI) using 27 Gy in 5 daily fractions. Pract Radiat Oncol. 2019;9(5):e457\u2013e64. https:\/\/doi.org\/10.1016\/j.prro.2019.04.002.","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"384_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ijrobp.2012.01.039","volume":"84","author":"SC Formenti","year":"2012","unstructured":"Formenti SC, Hsu H, Fenton-Kerimian M, Roses D, Guth A, Jozsef G, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. Int J Radiat Oncol Biol Phys. 2012;84(3):606\u201311. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.039.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR41","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.1016\/S0167-8140(17)31008-3","volume":"123","author":"B Meduri","year":"2017","unstructured":"Meduri B, Baldissera A, Galeandro M, Donini E, Tolento G, Giacobazzi P, et al. OC-0568: accelerated PBI VS standard radiotherapy (IRMA trial): interim cosmetic and toxicity results. Radiother Oncol. 2017;123:S303.","journal-title":"Radiother Oncol"},{"issue":"4","key":"384_CR42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ijrobp.2010.01.059","volume":"77","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Yarnold JR. Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations. Int J Radiat Oncol Biol Phys. 2010;77(4):969\u201373. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.01.059.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"384_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijrobp.2010.09.041","volume":"82","author":"M Palta","year":"2012","unstructured":"Palta M, Yoo S, Adamson JD, Prosnitz LR, Horton JK. Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012;82(1):37\u201342. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.09.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"384_CR44","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ijrobp.2015.03.007","volume":"92","author":"JK Horton","year":"2015","unstructured":"Horton JK, Blitzblau RC, Yoo S, Geradts J, Chang Z, Baker JA, et al. Preoperative single-fraction partial breast radiation therapy: a novel phase 1, dose-escalation protocol with radiation response biomarkers. Int J Radiat Oncol Biol Phys. 2015;92(4):846\u201355. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.007.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"384_CR45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.radonc.2015.09.023","volume":"117","author":"RK Charaghvandi","year":"2015","unstructured":"Charaghvandi RK, den Hartogh MD, van Ommen AM, de Vries WJ, Scholten V, Moerland MA, et al. MRI-guided single fraction ablative radiotherapy for early-stage breast cancer: a brachytherapy versus volumetric modulated arc therapy dosimetry study. Radiother Oncol. 2015;117(3):477\u201382. https:\/\/doi.org\/10.1016\/j.radonc.2015.09.023.","journal-title":"Radiother Oncol"},{"issue":"4","key":"384_CR46","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ijrobp.2016.11.030","volume":"97","author":"E Nichols","year":"2017","unstructured":"Nichols E, Kesmodel SB, Bellavance E, Drogula C, Tkaczuk K, Cohen RJ, et al. Preoperative accelerated partial breast irradiation for early-stage breast cancer: preliminary results of a prospective, phase 2 trial. Int J Radiat Oncol Biol Phys. 2017;97(4):747\u201353. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.11.030.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"384_CR47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ijrobp.2019.12.037","volume":"106","author":"SCJ Bosma","year":"2020","unstructured":"Bosma SCJ, Leij F, Vreeswijk S, Maaker M, Wesseling J, Vijver MV, et al. Five-year results of the preoperative accelerated partial breast irradiation (PAPBI) trial. Int J Radiat Oncol Biol Phys. 2020;106(5):958\u201367. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.12.037.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10237","key":"384_CR48","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"\u2022\u2022 Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395(10237):1613\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(20)30932-6. In this randomized trial women with early stage breast cancer were randomized to receive 26Gy or 27Gy in 5 daily fractions over 1 week to the whole breast, or 40Gy in 15 daily fractions over 3 weeks to the whole breast. The short courses were non-inferior compared to 3 weeks of radiation with regards to local control. 27Gy to the whole breast resulted in higher rates of breast toxicity, while 26Gy did not.","journal-title":"Lancet"},{"key":"384_CR49","doi-asserted-by":"publisher","unstructured":"Murray Brunt A, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A et al. Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer. J Clin Oncol. 2020:JCO1902750. https:\/\/doi.org\/10.1200\/JCO.19.02750.","DOI":"10.1200\/JCO.19.02750"},{"key":"384_CR50","doi-asserted-by":"publisher","unstructured":"Whelan T, Levine M, Sussman J. Hypofractionated breast irradiation: what's next? J Clin Oncol. 2020:JCO2001243. https:\/\/doi.org\/10.1200\/JCO.20.01243.","DOI":"10.1200\/JCO.20.01243"},{"issue":"19","key":"384_CR51","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382\u20137. https:\/\/doi.org\/10.1200\/JCO.2012.45.2615.","journal-title":"J Clin Oncol"},{"issue":"10","key":"384_CR52","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1056\/NEJMoa040595","volume":"351","author":"AW Fyles","year":"2004","unstructured":"Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351(10):963\u201370. https:\/\/doi.org\/10.1056\/NEJMoa040595.","journal-title":"N Engl J Med"},{"key":"384_CR53","unstructured":"A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer (LUMINA) Status: Active, not recruiting. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01791829. Accessed 18 May 2020."},{"key":"384_CR54","unstructured":"The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer Status: Recruiting. Available online: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02653755. Accessed 18 May 2020."},{"key":"384_CR55","unstructured":"The IDEA Study (individualized decisions for endocrine therapy alone) status: active, not recruiting. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02400190. Accessed 18 May 2020."},{"key":"384_CR56","unstructured":"Examining Personalised Radiation Therapy for Low-risk Early Breast Cancer (EXPERT) Status: Recruiting. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02889874. Accessed 18 May 2020."},{"key":"384_CR57","unstructured":"Exclusive Endocrine Therapy Or Partial Breast Irradiation for Women Aged \u226570 Years With Luminal-A Early Stage Breast Cancer (EUROPA) (EUROPA) Status: Not yet recruiting. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04134598. Accessed 18 May 2020."}],"container-title":["Current Breast Cancer Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12609-020-00384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12609-020-00384-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12609-020-00384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:16:25Z","timestamp":1744179385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12609-020-00384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,18]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1007\/s12609-020-00384-x","relation":{},"ISSN":["1943-4588","1943-4596"],"issn-type":[{"value":"1943-4588","type":"print"},{"value":"1943-4596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,18]]},"assertion":[{"value":"24 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Mira Goldberg and Timothy Whelan have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}